You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

7 Results
Guidelines and Advice
Status: In-Review
ID: 4-8
Version: 4
Jul 2019
Guidelines and Advice
Status: In-Review
ID: SCT 6
Feb 2016
Guidelines and Advice
Status: Current
ID: SCT-2
Version: 2
Nov 2019
Guidelines and Advice
Status: Current
ID: GL-C50-26
Feb 2016
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
SORAfenib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer facts
Jun 2019
Guidelines and Advice
Status: Current
Sep 2019